메뉴 건너뛰기




Volumn 34, Issue 4, 2006, Pages 1286-1287

Antifungal prophylaxis in the intensive care unit: Who should get it?

Author keywords

Antifungal therapy; Candida; Intensive care unit; Meta analysis; Prophylaxis

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

EID: 33645798646     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000208110.36504.19     Document Type: Editorial
Times cited : (7)

References (15)
  • 1
    • 0242659142 scopus 로고    scopus 로고
    • Attributable mortality of nosocomial candidemia, revisited
    • Gudlaugsson O, Gillespie S, Lee K, et al: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37:1172-1177
    • (2003) Clin Infect Dis , vol.37 , pp. 1172-1177
    • Gudlaugsson, O.1    Gillespie, S.2    Lee, K.3
  • 2
    • 0035870646 scopus 로고    scopus 로고
    • Prophylactic antifungal therapy in the intensive care unit
    • Rex JH, Sobel JD: Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 2001; 32:1191-1200
    • (2001) Clin Infect Dis , vol.32 , pp. 1191-1200
    • Rex, J.H.1    Sobel, J.D.2
  • 3
    • 12844257414 scopus 로고    scopus 로고
    • Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: Concepts and considerations
    • Lipsett PA: Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: Concepts and considerations. Clin Infect Dis 2004; 39:S193-S199
    • (2004) Clin Infect Dis , vol.39
    • Lipsett, P.A.1
  • 4
    • 8744260562 scopus 로고    scopus 로고
    • Prophylaxis and treatment of invasive candidiasis in the intensive care setting
    • Ostrosky-Zeichner L: Prophylaxis and treatment of invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2004; 23:739-744
    • (2004) Eur J Clin Microbiol Infect Dis , vol.23 , pp. 739-744
    • Ostrosky-Zeichner, L.1
  • 5
    • 0035080325 scopus 로고    scopus 로고
    • Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients
    • Pelz RK, Hendrix CW, Swoboda SM, et al: Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233:542-548
    • (2001) Ann Surg , vol.233 , pp. 542-548
    • Pelz, R.K.1    Hendrix, C.W.2    Swoboda, S.M.3
  • 6
    • 0033047638 scopus 로고    scopus 로고
    • Fluconazole prophylaxis prevents intraabdominal candidiasis in high-risk surgical patients
    • Eggimann P, Francioli P, Bille J, et al: Fluconazole prophylaxis prevents intraabdominal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27:1066-1072
    • (1999) Crit Care Med , vol.27 , pp. 1066-1072
    • Eggimann, P.1    Francioli, P.2    Bille, J.3
  • 7
    • 33645833237 scopus 로고    scopus 로고
    • Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials
    • Vardakas KZ, Samonis G, Michalopoulos A, et al: Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006; 34:1216-1224
    • (2006) Crit Care Med , vol.34 , pp. 1216-1224
    • Vardakas, K.Z.1    Samonis, G.2    Michalopoulos, A.3
  • 8
    • 0036453937 scopus 로고    scopus 로고
    • Prevention of severe Candida infections in non-neutropenic, high- Risk, critically ill patients: A randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination
    • Garbino J, Lew DP, Romand JA, et al: Prevention of severe Candida infections in non-neutropenic, high- risk, critically ill patients: A randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002; 28:1708-1717
    • (2002) Intensive Care Med , vol.28 , pp. 1708-1717
    • Garbino, J.1    Lew, D.P.2    Romand, J.A.3
  • 9
    • 0141433193 scopus 로고    scopus 로고
    • Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: A prospective, randomized, double-blind study
    • Sharpe MD, Ghent C, Grant D, et al: Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: A prospective, randomized, double-blind study. Transplantation 2003; 76:977-983
    • (2003) Transplantation , vol.76 , pp. 977-983
    • Sharpe, M.D.1    Ghent, C.2    Grant, D.3
  • 10
    • 0032758271 scopus 로고    scopus 로고
    • Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial
    • Winston DJ, Pakrasi A, Busuttil RW: Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131:729-737
    • (1999) Ann Intern Med , vol.131 , pp. 729-737
    • Winston, D.J.1    Pakrasi, A.2    Busuttil, R.W.3
  • 11
    • 0023113443 scopus 로고
    • Ketoconazole prevents Candida sepsis in critically ill surgical patients
    • Slotman GJ, Burchard KW: Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 1987; 122:147-151
    • (1987) Arch Surg , vol.122 , pp. 147-151
    • Slotman, G.J.1    Burchard, K.W.2
  • 12
    • 0036720774 scopus 로고    scopus 로고
    • Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999
    • Trick WE, Fridkin SK, Edwards JR, et al: Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35:627-630
    • (2002) Clin Infect Dis , vol.35 , pp. 627-630
    • Trick, W.E.1    Fridkin, S.K.2    Edwards, J.R.3
  • 13
    • 0037137576 scopus 로고    scopus 로고
    • Comparison of caspofungin and amphotericin B for invasive candidiasis
    • Caspofungin Invasive Candidiasis Study Group
    • Mora-Duarte J, Betts R, Rotstein R, et al: Caspofungin Invasive Candidiasis Study Group. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347:2020-2029
    • (2002) N Engl J Med , vol.347 , pp. 2020-2029
    • Mora-Duarte, J.1    Betts, R.2    Rotstein, R.3
  • 14
    • 1642420267 scopus 로고    scopus 로고
    • Caspofungin resistance in Candida albicans: Correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis
    • Hernandez S, Lopez-Ribot JL, Najvar LK, et al: Caspofungin resistance in Candida albicans: Correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis. Antimicrob Agents Chemother 2004; 48: 1382-1383
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 1382-1383
    • Hernandez, S.1    Lopez-Ribot, J.L.2    Najvar, L.K.3
  • 15
    • 19044386459 scopus 로고    scopus 로고
    • Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate
    • Goodman D, Pamer E, Jakubowski A, et al: Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clin Infect Dis 2002; 35: E35-E36
    • (2002) Clin Infect Dis , vol.35
    • Goodman, D.1    Pamer, E.2    Jakubowski, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.